Close Menu

US Patent No. 9,399,765

Construction of new variants of dextransucrase DSR-S by genetic engineering
Jul 28, 2016

Centre National de la Recherche Scientifique, Institut National de Recherche Scientifique, and Institut National des Sciences Appliquees de TouLouse have been awarded US Patent No. 9,399,765, "Construction of new variants of dextransucrase DSR-S by genetic engineering."

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.

Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Sponsored by

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.